Will SGI FY2026 Adjusted EPS land above the $3.20 midpoint?

Q1 2026 preview at +14% sales / +20% EPS is above the implied 20% FY guide midpoint pace. With Mattress Firm synergy capture ahead of schedule, $225M raised target, and 50% FCF buyback tailwind on share count, the setup favors above-midpoint delivery if industry holds flat. However, 3 of 4 quarters are unknown, industry is in trough with guide explicitly excluding recovery, and management's 'light' framing suggests they're managing expectations carefully. Base rate for a conservatively-guided company tracking above pace in Q1 to deliver above midpoint: ~55-60%. Landing at 0.58 reflects the Q1 positive start offset by 3Q remaining uncertainty and cyclical industry risk.

Structural view: midpoint beat requires +$0.01 above $3.20 on a $3.00-$3.40 range, so conceptually this is really 'will EPS land in upper half of range?' Base rate for conservatively-guided consumer durables hitting upper half of a 13% range is ~50-60%. Pro: Q1 pace, synergies, management track record of raises (raised 2028 target $4.85 to $5.15). Con: industry at -30% trend level, advertising spend $720M is large floor, Leggett integration distraction in H2 risk, interest rate sensitivity ($0.18-0.20/100bps). Probability 0.55 slightly favors YES given revealed-preference signals from management.

Decomposition: $3.20 midpoint = ~$686M net income on 214M shares. Q1 at +20% EPS on $0.55 base would be ~$0.66, annualizing to $2.64 on Q1 alone (but Q1 is seasonal). Full-year math: Q1 strong, Q2-Q4 normal seasonal = $3.25-$3.30 likely if no disruption. Adjust downward for (a) Leggett-integration-costs disclosed at close (could hit adjusted EPS depending on definition), (b) H2 advertising escalation, (c) interest rate stickiness. Net probability slightly above 0.55 at 0.60 — the Q1 start plus synergy tailwind outweighs the downside tail risks.

The question is structurally tight — $3.20 midpoint is the exact midpoint of $3.00-$3.40. Management track record of raising mid-year guides on prior deals (Sealy, Tempur Sealy consolidation) and 2028 raise suggests conservative floor. Q1 preview +20% EPS validates pace. Main downside: industry extending trough, Leggett execution distraction, interest expense risk. Net slightly above coin flip at 0.55.

Structural view: guidance ranges are typically set so midpoint has ~50% chance, but management track record of raising intra-year is evidence of lower-end anchoring. Offsetting: $720M advertising spend is a large floor that can be cut or raised; industry deterioration directly hits revenue at 65% direct concentration; interest rate scenarios asymmetric. Net 0.53 — slightly above 50% but not confidently.

Weight of evidence: Q1 pace confirmed above FY rate, synergy ahead of schedule, international growth engine durable, management credibility strong. Weight against: industry trough, 65% direct exposure, advertising floor, interest rate risk. On balance, the positive evidence is clearer and more specific (Q1 numbers, synergy dollars) while negative is macro/systemic (trough continuation). Landing at 0.57 — favoring YES but not strongly.

Q1 2026 preview at +20% EPS suggests above-pace start. Management track record on synergies and guide raises is solid. Industry trough risk and interest rate sensitivity are offsetting. Coin-flip-plus at 0.55.

Coin flip with slight upward tilt. Pro: Q1 preview, synergies ahead, 2028 raise. Con: industry trough, advertising floor, interest rate sensitivity. Settle at 0.52.

Base rate for conservatively-guided companies with strong Q1 starts to beat midpoint is ~55-65%. Q1 preview +14% sales / +20% EPS is above guide pace. Mattress Firm synergy capture $80M in 2025 validates trajectory. Main risk is H2 industry weakness. Net 0.56.